Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis.

Lind, Jennifer N; Lovegrove, Maribeth C; Geller, Andrew I; Uyeki, Timothy M; Datta, S Deblina; Budnitz, Daniel S

Lind, Jennifer N; Lovegrove, Maribeth C; Geller, Andrew I; Uyeki, Timothy M; Datta, S Deblina; Budnitz, Daniel S.

Lind JN; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA. jlind@cdc.gov.
Lovegrove MC; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Geller AI; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Uyeki TM; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Datta SD; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Budnitz DS; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, GA, USA.

J Gen Intern Med ; 36(9): 2909-2911, 2021 09.

Article in English | MEDLINE | ID: covidwho-1274925

Subject(s)

COVID-19 Drug Treatment; Ivermectin/administration & dosage; Pandemics; Cross-Sectional Studies; Humans; Outpatients; United States

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ivermectin / Pandemics / COVID-19 Drug Treatment Type of study: Observational study / Randomized controlled trials Limits: Humans Country/Region as subject: North America Language: English Journal: J Gen Intern Med Journal subject: Internal Medicine Year: 2021 Document Type: Article Affiliation country: S11606-021-06948-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google